(1′R,3R)-(+)-1-(1′-苯乙基)-5-氧代-3-吡咯烷羧酸, 98%

(1′R,3R)-(+)-1-(1′-Phenylethyl)-5-oxo-3-pyrrolidinecarboxylic acid

(1R,1'R)-1,1'-二(二环己基膦)-2,2'-二[(R)-(二甲基氨基)苯基甲基]二茂铁, 99%

(1R,1'R)-1,1'-Bis(dicyclohexylphosphino)-2,2'-bis[(R)-(dimethylamino)phenylmethyl]ferrocene

1,2-双((2R,5R)-2,5-二异丙基磷杂环戊烷-1-基)苯, 99%

1,2-Bis((2R,5R)-2,5-diisopropylphospholan-1-yl)benzene

(5S)-(-)-5-(三氟甲基)-2-吡咯烷酮

(5S)-(−)-5-(Trifluoromethyl)-2-pyrrolidinone

98%

(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥98%,99.9%e.e.

(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

3-甲基吡唑并[1,5-a]吡啶-2-羧酸乙酯, 98%

Ethyl 3-methylpyrazolo[1,5-a]pyridine-2-carboxylate

(11BR)-2,6-双(3,5-二氯苯基)-4-羟基二萘并[2,1-d:1',2'-f][1,3,2]二氧膦杂环庚三烯 4-氧化物, 99%

(11bR)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

R-3,3’-双(3,5-双(三氟甲基)苯基)-1,1’-联-2-萘酚, 99%，ee99.9%

(R)-3,3'-Bis(3,5-bis(trifluoromethyl)phenyl)-[1,1'-binaphthalene]-2,2'-diol

（4S）-4-i-丙基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯

(S)-3-Boc-4-isopropyl-2,2-dioxo-[1,2,3]oxathiazolidine

≥98%

（4S）-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯

(S)-3-Boc-4-tert-butyl-2,2-dioxo-[1,2,3]oxathiazolidine

≥98%

(8α,9S)-6'-甲氧基辛可宁-9-胺三盐酸盐, 98%

(8α,9S)-6'-Methoxycinchonan-9-amine trihydrochloride

(1S,2R)-2-氨基环戊醇盐酸盐, 99%

(1S,2R)-2-Aminocyclopentanol hydrochloride

(R)-4-苯基丁烷-2-醇, 98%

(R)-(-)-4-Phenyl-2-butanol

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

GSK-3抑制剂XIII

GSK-3 Inhibitor XIII

99%

1-{(1S,2R)-1-[(11bR)-2,6-二甲基二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷杂七-4-基氧基]-1-苯基丙-2-基}-3-苯基脲

1-{(1S,2R)-1-[(11bR)-2,6-Dimethyldinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]-1-phenylpropan-2-yl}-3-phenylurea

98%

(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基恶唑], 99%，ee99.9%

(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

1-{2S）-1-[（11bR）-2,6-双（三甲基甲硅烷基）二萘并[2,1-d：1''，2''-f] [1,3,2]二氧杂磷-4-氧基]丙烷-2-基}-3-苯基脲

1-{2S)-1-[(11bR)-2,6-Bis(trimethylsilyl)dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]propan-2-yl}-3-phenylurea

98%

(R)-3,3'-双(4-叔丁基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯, 99%

(11bR)-2,6-Bis(4-(tert-butyl)phenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide